Thomas Meier
Fortuna: 1 M $ al 31/07/2026
Fortuna: 1 M $ al 31/07/2026
El Sr. Thomas Meier es Director General de Bachem Holding AG y Presidente del Consejo de Supervisión de Bachem AG. Forma parte del Consejo de Administración de Bachem (U.K.) Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2025 | 13.966 ( 0,02 % ) | 1 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDIOS AG | Director Ejecutivo | 01/02/2026 |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures peptides and organic molecules | Director/Miembro de la Junta | 11/12/2018 |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Presidente | 01/01/1993 |
| Empresas | Cargo | Fin |
|---|---|---|
| BACHEM HOLDING AG | Director Ejecutivo | 01/01/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Bachem Holding AG
Bachem Holding AG Pharmaceuticals: MajorHealth Technology Operates as an independent, technology-based, public biochemical company | Health Technology |
Medios AG
Medios AG Medical DistributorsDistribution Services Engages in trading specialty pharmaceutical drugs | Distribution Services |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Health Technology |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures peptides and organic molecules | Health Technology |
Zhaw School of Engineering
Zhaw School of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.